These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3084300)
1. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. Coddington CC; Collins RL; Shawker TH; Anderson R; Loriaux DL; Winkel CA Fertil Steril; 1986 May; 45(5):624-9. PubMed ID: 3084300 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up. Letterie GS; Coddington CC; Winkel CA; Shawker TH; Loriaux DL; Collins RL Fertil Steril; 1989 Jun; 51(6):951-6. PubMed ID: 2498132 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313 [TBL] [Abstract][Full Text] [Related]
4. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587 [TBL] [Abstract][Full Text] [Related]
6. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Friedman AJ; Barbieri RL; Benacerraf BR; Schiff I Fertil Steril; 1987 Oct; 48(4):560-4. PubMed ID: 3115833 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous injection or infusion of gonadotropin releasing-hormone agonist buserelin in the treatment of enlarged uteri harboring leiomyomata. Franssen AM; Willemsen WN; Corbey RS; Doesburg WH; van 't Veen AJ; Rolland R Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(3):221-8. PubMed ID: 1908799 [TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148 [TBL] [Abstract][Full Text] [Related]
9. Use of gonadotropin-releasing hormone agonists before myomectomy. Friedman AJ Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611 [No Abstract] [Full Text] [Related]
10. Treatment of uterine leiomyomata with a luteinizing hormone-releasing hormone agonist: the possibility of nonsurgical management in selected perimenopausal women. Nakamura Y; Yoshimura Y; Yamada H; Ubukata Y; Ando M; Suzuki M Fertil Steril; 1991 May; 55(5):900-5. PubMed ID: 1902420 [TBL] [Abstract][Full Text] [Related]
11. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas. Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476 [TBL] [Abstract][Full Text] [Related]
12. Effects of the (imBzl)D-His6, Des-Gly analog of GnRH on gonadotropin and estradiol secretion in normal women. DeFazio J; Lu JK; Vale W; Rivier J; Judd HL; Meldrum DR Endocr Res; 1984; 10(2):163-70. PubMed ID: 6437804 [TBL] [Abstract][Full Text] [Related]
14. Differential reduction in the volume of leiomyoma and uterus during buserelin treatment. Puzigaća Z; Prelević GM; Sretenović Z Gynecol Endocrinol; 1994 Mar; 8(1):39-43. PubMed ID: 8059616 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Watanabe Y; Nakamura G; Matsuguchi H; Nozaki M; Sano M; Nakano H Fertil Steril; 1992 Jul; 58(1):66-71. PubMed ID: 1624025 [TBL] [Abstract][Full Text] [Related]
16. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH. van Leusden HA; Dogterom AA Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173 [TBL] [Abstract][Full Text] [Related]
17. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797 [TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study. Maheux R; Guilloteau C; Lemay A; Bastide A; Fazekas AT Am J Obstet Gynecol; 1985 Aug; 152(8):1034-8. PubMed ID: 3927734 [TBL] [Abstract][Full Text] [Related]
19. Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary report. Maheux R; Guilloteau C; Lemay A; Bastide A; Fazekas AT Fertil Steril; 1984 Oct; 42(4):644-6. PubMed ID: 6436065 [No Abstract] [Full Text] [Related]
20. Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist. Kettel LM; Murphy AA; Morales AJ; Rivier J; Vale W; Yen SS Fertil Steril; 1993 Oct; 60(4):642-6. PubMed ID: 8405517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]